 |
Mesoblast Limited
MESO
|
0.00568 |
$ 14.32 |
2.14 % |
$ 9.29 B |
Australia |
 |
Aeterna Zentaris
AEZS
|
146 |
- |
5.93 % |
$ 314 M |
Canada |
 |
Albireo Pharma
ALBO
|
14.7 |
- |
-0.23 % |
$ 916 M |
USA |
 |
I-Mab
IMAB
|
271 |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 |
- |
- |
$ 40.3 B |
USA |
 |
Ascendis Pharma A/S
ASND
|
132 |
$ 215.54 |
-1.16 % |
$ 5 B |
Danmark |
 |
Midatech Pharma plc
MTP
|
204 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Amphastar Pharmaceuticals
AMPH
|
70.9 |
$ 19.23 |
- |
$ 899 M |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.114 |
- |
- |
$ 26.5 M |
USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
239 |
$ 8.18 |
-2.97 % |
$ 109 M |
USA |
 |
MediciNova
MNOV
|
365 |
$ 1.45 |
- |
$ 71.1 M |
USA |
 |
AgeX Therapeutics
AGE
|
78.4 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Acorda Therapeutics
ACOR
|
48.3 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Acasti Pharma
ACST
|
1.97 |
- |
4.01 % |
$ 150 M |
Canada |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
9.68 |
$ 0.71 |
17.15 % |
$ 8.13 M |
Israel |
 |
Adverum Biotechnologies
ADVM
|
222 |
- |
- |
$ 86.2 M |
USA |
 |
Advaxis
ADXS
|
88.1 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Exelixis
EXEL
|
43.4 |
$ 41.57 |
0.39 % |
$ 11.3 B |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
61.7 |
- |
- |
$ 7.46 M |
Israel |
 |
ChemoCentryx
CCXI
|
3.1 |
- |
- |
$ 3.74 B |
USA |
 |
Genmab A/S
GMAB
|
97.9 |
$ 25.81 |
0.51 % |
$ 16.6 B |
Danmark |
 |
Aytu BioScience
AYTU
|
150 |
$ 2.65 |
0.76 % |
$ 16.6 M |
USA |
 |
BioDelivery Sciences International
BDSI
|
115 |
- |
-4.8 % |
$ 255 M |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
216 |
- |
- |
$ 1.01 B |
USA |
 |
CureVac N.V.
CVAC
|
13.6 |
- |
- |
$ 867 M |
Germany |
 |
BeiGene, Ltd.
BGNE
|
52.6 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
NovaBay Pharmaceuticals
NBY
|
34.4 |
$ 1.5 |
11.94 % |
$ 8.73 M |
USA |
 |
Arbutus Biopharma Corporation
ABUS
|
50 |
$ 4.31 |
-2.49 % |
$ 826 M |
Canada |
 |
AIkido Pharma
AIKI
|
17.9 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Ionis Pharmaceuticals
IONS
|
20.5 |
$ 69.68 |
-1.57 % |
$ 11.1 B |
USA |
 |
Brickell Biotech
BBI
|
254 |
- |
-5.38 % |
$ 6.06 M |
USA |
 |
Calithera Biosciences
CALA
|
28.8 |
- |
-10.95 % |
$ 876 K |
USA |
 |
Alpine Immune Sciences
ALPN
|
154 |
- |
- |
$ 2.17 B |
USA |
 |
Cara Therapeutics
CARA
|
52.4 |
- |
-3.03 % |
$ 260 M |
USA |